Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 18/20 | 0.58 |
| ▸ | TACR3 | P29371 | 2/20 | 0.58 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | FPR1 | P21462 | 1/20 | 0.58 |
| ▸ | GPR183 | P32249 | 1/20 | 0.58 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.58 |
| ▸ | GPR65 | Q8IYL9 | 1/20 | 0.58 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.58 |
| ▸ | TACR2 | P21452 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7759145 | 1.00 | TACR1 (0.58) | TACR1TACR3NR3C1CYP3A4FPR1 | |
| SCHEMBL3370723 | 1.00 | TACR1 (0.58) | TACR1TACR3NR3C1CYP3A4FPR1 | |
| SCHEMBL3370718 | 1.00 | TACR1 (0.58) | TACR1TACR3NR3C1CYP3A4FPR1 | |
| SCHEMBL3370721 | 1.00 | TACR1 (0.58) | TACR1TACR3NR3C1CYP3A4FPR1 | |
| SCHEMBL5224196 | 0.89 | TACR1 (0.55) | TACR1TACR3NR3C1CYP3A4FPR1 | |
| SCHEMBL6604634 | 0.88 | TACR1 (0.74) | TACR1TACR3NR3C1CYP3A4FPR1 | |
| SCHEMBL6604637 | 0.88 | TACR1 (0.74) | TACR1TACR3NR3C1CYP3A4FPR1 | |
| SCHEMBL5224202 | 0.88 | TACR1 (0.57) | TACR1TACR3NR3C1CYP3A4FPR1 | |
| SCHEMBL5223101 | 0.85 | TACR1 (0.80) | TACR1TACR3NR3C1CYP3A4FPR1 | |
| SCHEMBL5264189 | 0.85 | TACR1 (0.55) | TACR1TACR3NR3C1CYP3A4FPR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1087771-A1 | USE OF A NK-1 RECEPTOR ANTAGONIST FOR TREATING BIPOLAR DISORDERS | MERCK SHARP & DOHME LTD. (GB) | 2001-04-04 | — | — | EP | disclosed |
| WO-1999064007-A1 | USE OF A NK-1 RECEPTOR ANTAGONIST FOR TREATING BIPOLAR DISORDERS | MERCK SHARP & DOHME LIMITED (GB) | 1999-12-16 | — | — | WO | disclosed |